Mankind Pharma IPO vs Tata Technologies IPO

Comparison between Mankind Pharma IPO and Tata Technologies IPO.

IPO Details

Mankind Pharma IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tata Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Tata Technologies IPO is up to ₹3,042.51 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Tata Technologies IPO is ₹500.00 per share.

 Mankind Pharma IPOTata Technologies IPO
Face Value₹1 per share₹2 per share
Issue Price (Lower)₹1,026.00 per share₹475.00 per share
Issue Price (Upper)₹1,080.00 per share₹500.00 per share
Issue Price (Final)₹1,080.00 per share₹500.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size13 shares30 shares
Fresh Issue Size0 shares0 shares
Fresh Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
OFS Issue Size4,00,58,844 shares6,08,50,278 shares
OFS Issue Size (Amount)up to ₹4,326.36 Crup to ₹3,042.51 Cr
Issue Size Total4,00,58,844 shares6,08,50,278 shares
Issue Size Total (Amount)up to ₹4,326.36 Crup to ₹3,042.51 Cr

IPO Timetable

Mankind Pharma IPO opens on Apr 25, 2023, while Tata Technologies IPO opens on Nov 22, 2023. The closing date of Mankind Pharma IPO and Tata Technologies IPO is Apr 27, 2023, and Nov 24, 2023, respectively.

 Mankind Pharma IPOTata Technologies IPO
Anchor Bid DateApr 24, 2023Nov 21, 2023
Issue OpenApr 25, 2023Nov 22, 2023
Issue CloseApr 27, 2023Nov 24, 2023
Basis Of Allotment (Tentative)May 03, 2023Nov 28, 2023
Initiation of Refunds (Tentative)May 04, 2023Nov 29, 2023
Credit of Share (Tentative)May 05, 2023Nov 29, 2023
Listing date (Tentative)May 09, 2023Nov 30, 2023
Anchor Lockin End date 1Jun 02, 2023Dec 28, 2023
Anchor Lockin End date 2Aug 01, 2023Feb 26, 2024

Financials & KPIs

Mankind Pharma IPO P/E ratio is 32.5, as compared to Tata Technologies IPO P/E ratio of 32.53.

 Mankind Pharma IPOTata Technologies IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Dec 202231 Mar 202231 Dec 202131 Mar 202131 Mar 2020
Assets9,273.759,147.748,043.886,372.635,073.29
Total Income6,777.827,977.586,218.296,385.385,975.65
Profit After Tax1,015.981,452.961,260.241,293.031,056.15
NET Worth7,145.896,155.235,965.464,722.003,485.31
Reserves and Surplus7,094.126,106.065,916.864,674.393,436.34
Total Borrowing167.93868.03268.70234.53126.92
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets5,142.425,201.494,218.003,572.74
Total Income2,587.424,501.933,578.382,425.74
Profit After Tax351.90624.04436.99239.17
NET Worth2,853.132,989.472,280.162,142.15
Reserves and Surplus2,455.292,605.602,028.931,897.46
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)79.0066.79
Promoter Shareholding (Post-Issue)76.5055.39
P/E Ratio32.532.53
Market Cap₹43263.60 Cr.₹20283.43 Cr.
ROE27.60%
ROCE26.10%
Debt/Equity
EPS₹33.20₹15.37
RoNW27.70%20.87%

Shares Offered

In the Mankind Pharma IPO Retail Individual Investors (RII) are offered 1,40,20,596 shares while in Tata Technologies IPO retail investors are offered 1,40,20,596 shares. Qualified Institutional Buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 1,05,47,382 shares in Tata Technologies IPO.

 Mankind Pharma IPOTata Technologies IPO
Anchor Investor Reservation1,20,17,652 shares1,58,21,071 shares
Market Maker Reservation0 shares
QIB80,11,769 shares1,05,47,382 shares
NII60,08,827 shares79,10,537 shares
RII1,40,20,596 shares1,84,57,919 shares
Employee20,28,342 shares
Others
Total4,00,58,844 shares6,08,50,278 shares

Bids Received (Subscription)

Mankind Pharma IPO subscribed 15.32x in total, whereas Tata Technologies IPO subscribed 69.43x.

 Mankind Pharma IPOTata Technologies IPO
QIB (times)49.16x203.41x
NII (times)3.80x62.11x
Big NII (times)4.99x70.67x
Small NII (times)1.41x44.98x
RII (times)0.92x16.50x
Employee (times)3.70x
Other (times)29.20x
Total (times)15.32x69.43x

Compare with others

Compare:

Mankind Pharma IPO Vs Tata Technologies IPO